MEC Company Ltd.
Stock Price Chart
2026/11/11 12:12 UpdatedPrice Trend
2026/11/11 12:12 UpdatedPrice & Trading Details
2026/11/11 12:12 UpdatedPRICE
TRADING
Analyst Recommendations 3 analysts
Updated 2026/11/01Earnings Calendar
Updated 2026/11/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2023/11/10 | ¥23.00 | ¥33.60 | +46.1% |
| 2023/08/09 | ¥32.20 | ¥52.47 | +63.0% |
| 2009/05/14 | ¥-12.27 | ¥-22.70 | -85.0% |
| 2009/01/30 | ¥3.98 | ¥-1.38 | -134.7% |
Shareholder Composition
Updated 2026/11/01Top Mutual Funds / ETFs
Updated 2026/11/01Major Holders
Updated 2026/11/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
215.4K | +2.87% | |
|
Manager Directed Portfolios-Hood River International Opportunity Fund
|
199.9K | -7.97% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
143.4K | 0.00% | |
|
Fidelity Investment Trust-Fidelity Japan Fund
|
128.6K | 0.00% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
109.6K | +12.18% | |
|
Dimensional ETF Trust-Dimensional International Small Cap ETF
|
69.8K | +1.45% |
Dividend History
Updated 2026/11/08| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥55 | -42.7% |
| 2025 | ¥96 | +113.3% |
| 2024 | ¥45 | 0.0% |
| 2023 | ¥45 | 0.0% |
| 2022 | ¥45 | - |
Financial Performance
2026/11/08 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥15,038M | ¥16,329M | ¥14,020M | ¥18,234M |
| Gross Profit | ¥9,323M | ¥9,804M | ¥8,317M | ¥11,102M |
| Operating Income | ¥3,940M | ¥4,004M | ¥2,493M | ¥4,562M |
| Pretax Income | ¥4,093M | ¥4,225M | ¥3,220M | ¥4,671M |
| Net Income | ¥2,949M | ¥3,065M | ¥2,305M | ¥2,292M |
| EPS | ¥155.28 | ¥161.22 | ¥122.29 | ¥122.29 |
| Operating Margin | 26.20% | 24.52% | 17.78% | 25.02% |
| Balance Sheet | ||||
| Total Assets | ¥25,305M | ¥27,499M | ¥28,665M | ¥33,039M |
| Total Equity | ¥20,929M | ¥23,326M | ¥24,777M | ¥26,897M |
| Total Liabilities | ¥4,376M | ¥4,173M | ¥3,888M | ¥6,142M |
| Cash | ¥7,153M | ¥9,443M | ¥8,756M | ¥11,476M |
| Interest-bearing Debt | ¥0M | - | - | - |
| Equity Ratio | 82.71% | 84.82% | 86.44% | 81.41% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow | ||||
| Operating CF | ¥3,014M | ¥3,811M | ¥1,941M | ¥4,200M |
| Investing CF | -¥1,118M | -¥939M | -¥1,398M | ¥52M |
| Financing CF | -¥916M | -¥800M | -¥1,774M | -¥873M |
| Free CF | ¥2,310M | ¥3,208M | ¥59M | ¥3,441M |
| Efficiency | ||||
| ROE | 14.09% | 13.14% | 9.30% | 8.52% |
| ROA | 11.66% | 11.14% | 8.04% | 6.94% |
Latest IR Information
-
Notice Regarding Determination of Matters Concerning Share Acquisition under the Stock Compensation Plan
The board resolved to continue the stock delivery trusts for directors and executive officers and to make additional monetary contributions to the trusts so that the trustee will acquire additional shares. Total acquisition amounts are 57,887,000 yen for directors and...
Read more -
Fiscal Year Ending December 2026, Third Quarter Financial Summary (Japanese GAAP) (Consolidated)
For the nine months ended the third quarter of FY2026, consolidated revenue was 19,730 million yen, operating income was 6,696 million yen, and net income attributable to owners of parent was 4,823 million yen. Full-year forecasts were revised to revenue...
Read more -
Fiscal Year Ending December 2026 Q3 Earnings Presentation Materials
Net sales were 19,730 million yen (Year-over-Year (YoY) increase of 31.6%), operating income was 6,696 million yen (YoY increase of 57.6%). Pharmaceutical product sales were 19,361 million yen, and shipment volume was 41,596 tons. Overall profit contribution including foreign exchange...
Read more -
Notice of Revision to Earnings Guidance
Revised consolidated earnings guidance for the fiscal year ending December 2026. Net sales increased by 700 million yen from the previous forecast to 26,500 million yen, operating income increased by 300 million yen to 8,600 million yen, ordinary income increased...
Read more -
Notice Regarding Disposal of Treasury Shares in Connection with Continuation of Stock Compensation Plan
In connection with the continuation of the stock compensation plan for directors and executive officers, MEC Company Ltd. will dispose of 14,200 shares. The disposal price is 5,410 yen per share, total amount 76,822,000 yen. Allocation is 10,700 shares for...
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥8,650
Rating Score: 1.50 (Based on 3 analysts)
※1=Strong Buy, 5=Strong Sell
Mec Co Ltd - To Conduct 3-For-1 Share Split For Shareholders As Of December 31 - TradingView ↗
Company Information
About
MEC Company Ltd. engages in the research and development, production, and sale of chemicals, equipment, and related materials for the production of printed circuit boards in Japan, Taiwan, Hong Kong, China, Thailand, and Europe. It offers various chemicals for electronic substrates, such as roughening type adhesion enhancement; rolled annealed copper roughening treatment; pre-lamination treatment of multilayer substrates and adhesion enhancement for high-frequency substrates; anisotropic etching and seed layer etching; copper surface treatment for CO2 laser direct drilling; degreasing, rust removal, and temporary anti-tarnish; other metal surface treatment; DFR pre-treatment; microetching; etch down; and various residue removal treatments. The company also provides AMALPHA, a metal surface treatment technology for direct metal and resin bonding. MEC Company Ltd. was incorporated in 1969 and is headquartered in Amagasaki, Japan.
